Bloating Is Common In People With Ulcerative Colitis: Expert Explains Its Causes And Management Tips
Ulcerative Colitis UC is a chronic inflammatory bowel disease that can lead to frequent bloating Read on to learn its causes ...
Persistent care barriers may lead patients with inflammatory bowel disease (IBD) to ration medication or skip doses. The ...
The most common reason for delaying or not receiving care was not getting an appointment when they needed one, cited by 39% of respondents. More than half (56%) of patients reported delays in ...
Despite advances in treatment for inflammatory bowel disease, more than 55% of patients report medication delays, mostly due ...
A study led by the University of Birmingham found that vancomycin, a commonly used antibiotic for diarrhea, could effectively treat a type of inflammatory bowel disease (IBD) linked to autoimmune ...
Vancomycin could offer new therapeutic option for patients with a type of inflammatory bowel disease
An antibiotic used to treat infective diarrhoea could be an effective drug for a type of inflammatory bowel disease, a new study has found.
An antibiotic used to treat infective diarrhea could be an effective drug for a type of inflammatory bowel disease, a new ...
The Levy family is excited to be recognized as the 2025 New England Take Steps Honored Family, and Soliel as the Honored Hero ...
For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major ...
Older adults with moderate to severe IBD can achieve remission with JAK inhibitors, according to a study presented at Crohn’s & Colitis Congress.
Better cardiovascular safety and lower risk of all-cause mortality was observed among older adult patients with IBD who received ustekinumab vs vedolizumab.
No significant difference in the risk for MACE was observed between patients with IBD receiving JAK vs TNF inhibitors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results